Tarsus Pharmaceuticals, Inc.
2022 Q1 - 2025 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 59,661 | 1.6% | 728,644 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 69,386 | 2.1% | 1,167,527 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 56,614 | 2.3% | 1,397,527 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 71,791 | 3.3% | 1,397,527 | 3/31/2025 |
| 2024 Q4 | 2/18/2025 | 87,901 | 3.6% | 1,587,527 | 12/31/2024 |
| 2024 Q3 | 11/15/2024 | 52,214 | 2.1% | 1,587,527 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 43,149 | 2.0% | 1,587,527 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 64,977 | 2.7% | 1,787,527 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 36,197 | 1.9% | 1,787,527 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 31,764 | 2.1% | 1,787,527 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 32,301 | 1.9% | 1,787,527 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 22,469 | 1.6% | 1,787,527 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 26,205 | 1.6% | 1,787,527 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 30,602 | 2.4% | 1,787,527 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 26,098 | 2.5% | 1,787,527 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 23,837 | 2.0% | 1,417,157 | 3/31/2022 |